Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001493152-17-010887)

Filing Details

Accession Number:: 0001493152-17-010887
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-09-25 17:48:30
Reporting Period:: 2017-09-15

Accepted Time:: 2017-09-25 17:48:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
883975	Microbot Medical Inc.	MBOT	Biological Products, (No Disgnostic Substances) (2836)	943078125

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1690161	Moshe Shoham	C/O Microbot Medical Inc. 25 Recreation Park Drive, Unit 108 Hingham MA 02043		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-09-15	74,975	$1.25	1,592,090	No	4	S	Direct
Common Stock	Disposition	2017-09-15	28,657	$1.26	1,592,090	No	4	S	Direct
Common Stock	Disposition	2017-09-15	40,500	$1.26	1,592,090	No	4	S	Direct
Common Stock	Disposition	2017-09-15	20,276	$1.27	1,592,090	No	4	S	Direct
Common Stock	Disposition	2017-09-15	400	$1.27	1,592,090	No	4	S	Direct
Common Stock	Disposition	2017-09-15	27,384	$1.27	1,592,090	No	4	S	Direct
Common Stock	Disposition	2017-09-15	1,200	$1.28	1,592,090	No	4	S	Direct
Common Stock	Disposition	2017-09-15	14,400	$1.28	1,592,090	No	4	S	Direct
Common Stock	Disposition	2017-09-15	11,083	$1.29	1,592,090	No	4	S	Direct
Common Stock	Disposition	2017-09-15	6,463	$1.29	1,592,090	No	4	S	Direct
Common Stock	Disposition	2017-09-15	9,001	$1.30	1,592,090	No	4	S	Direct
Common Stock	Disposition	2017-09-15	6,500	$1.30	1,592,090	No	4	S	Direct
Common Stock	Disposition	2017-09-15	1,471	$1.31	1,592,090	No	4	S	Direct
Common Stock	Disposition	2017-09-15	7,490	$1.31	1,592,090	No	4	S	Direct
Common Stock	Disposition	2017-09-15	200	$1.32	1,592,090	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 250,000 shares of Issuer common stock on September 15, 2017. Accordingly, Reporting Person beneficially owned 1,592,090 shares of Issuer common stock following the reported transactions.